James F Reddoch - EVP, Royalty Pharma Plc

As of July 27, 2021


James F Reddoch Net Worth

  • Net worth is estimated to be at least $25.82M
  • Owns at least 1,195,830 units of Royalty Pharma Plc stock
  • Sold an estimated value of $24.86M in the last year at Royalty Pharma Plc

James F Reddoch Compensation at Royalty Pharma Plc in 2020

  • Received a total compensation of $

James F Reddoch Trading

  • Largest sale of shares was 200,000 units , worth over $9.11M on June 8, 2021
  • In total has made about 13 transactions over a year
  • Usually trades in July, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James F Reddoch Mailing Address

  • Mailing address is C/o Royalty Pharma Plc 110 East 59th Street New York NY 10022 NY

Royalty Pharma Plc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Pablo Legorreta Pablo Legorreta 2020 $55,674,558 $55,674,558 $55,674,558 $55,674,558
Pablo Legorreta Pablo Legorreta 2019 $28,545,792 $28,545,792 $28,545,792 $28,545,792
Terrance Coyne Terrance Coyne 2020 $3,395,000 $3,395,000 - $3,395,000
Terrance Coyne Terrance Coyne 2019 $1,925,625 $1,925,625 - $1,925,625
Christopher Hite 2020 $3,644,711 $3,644,711 $367,788 $3,644,711
Christopher Hite 2019 - - - -
George Lloyd George Lloyd 2020 $3,395,000 $3,395,000 - $3,395,000
George Lloyd George Lloyd 2019 $2,182,500 $2,182,500 - $2,182,500
James Reddoch, Ph.D. James Reddoch, Ph.D. 2020 $3,395,000 $3,395,000 - $3,395,000
James Reddoch, Ph.D. James Reddoch, Ph.D. 2019 $2,082,500 $2,082,500 - $2,082,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm

Royalty Pharma Plc Insider Trading

  • The most recent transaction was 1,064,852 units sold on September 30, 2021 by Rory B Riggs worth over $4.69M
  • In the last 5 years, insiders at Royalty Pharma Plc sold an estimated value of $470.74M and bought an estimated value of $144.93M
  • The most active traders are George W Lloyd, EVP,  James F Reddoch, EVP,  and Katherine Anderson, CHIEF FINANCIAL OFFICER
  • Insider trading is most common in June, with the busiest year in 2021

REPROS THERAPEUTICS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1